Navigation Links
Statement by John Bailey, Chief Scientist: The Personal Care Products Council Response to Study on Phthalate Exposure in Baby Care Products
Date:2/4/2008

WASHINGTON, Feb. 4 /PRNewswire/ -- A recent study published this month in the journal, Pediatrics, suggests that the use of baby lotion, powder, and shampoo is linked to the presence of phthalates in babies. Phthalates are a large family of compounds used in a wide variety of everyday products. They are used primarily as plasticizers, giving flexibility to rubber, plastic, or resin and can also be used to stabilize and make fragrances work properly. The study's researchers analyzed urine concentrations of nine different phthalate metabolites in 163 infants and concluded that the use of these baby products resulted in higher levels of phthalates in the infants. John Bailey of the Personal Care Products Council issued the following statement:

"The results of this study suggesting a link between the use of baby lotion, shampoo, and powder and the presence of phthalates in infants do not make sense because only one of the seven phthalate compounds reported is even used in baby care products. This suggests that most of the phthalates found in the urine samples came from another route of exposure, and we welcome additional study to determine the source.

"The one phthalate that is sometimes found in baby care products is diethyl phthalate (DEP). DEP, which is a component of some fragrance preparations, may be present at very low levels in baby care products. No other phthalates are used in fragrance ingredients. Both the Cosmetic Ingredient Review (CIR) Expert Panel, an independent, nonprofit panel of scientists and physicians who assess the safety of personal care product ingredients in the U.S., and the Scientific Committee on Consumer Products (SCCP), the body that advises the European Union Commission on safety matters related to cosmetics, determined DEP to be safe. DEP has been extensively researched and is not linked to reproductive toxicity or endocrine disruption.

"Unfortunately, the researchers of this study did not test baby care products for the presence of phthalates or control for other possible routes of exposure. A 2006 study conducted by the U.S. Food and Drug Administration (FDA) found that with the exception of DEP, no other phthalates were present in the baby product tested. For this reason, we question the validity of the alleged link between the use of baby personal care products and the presence of phthalates in infants."

Based in Washington, D.C., the Personal Care Products Council is the leading national trade association representing the $250 billion global cosmetic and personal care products industry. Founded in 1894, the Council's more than 600 member companies manufacture, distribute, and supply the vast majority of finished personal care products marketed in the U.S. As the makers of a diverse range of products millions of consumers rely on everyday, from sunscreens, toothpaste and shampoo to moisturizer, lipstick and fragrance, personal care products companies are global leaders committed to product safety, quality and innovation.


'/>"/>
SOURCE Personal Care Products Council
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
2. Smithfield Foods, Inc. Statement Regarding Animal Cloning
3. Statement on the Release of the European Food Safety Assessment on the Safety of Food Derived From Clones and Their Offspring in the Food Supply
4. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
5. /CORRECTION//- RxElite Temporarily Suspends Sales Under Its Registration Statement
6. Reliant Pharmaceuticals Announces the Filing of Registration Statement on Form S-1 For an Initial Public Offering
7. Statement of International Dairy Foods Association President and CEO Connie Tipton
8. National Stem Cell Holding, Inc. Posts Company and Financial Information on the OTCIQ and Has Retained New CFO and Counsel to File Registration Statement With SEC
9. Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement and Release Date of Third Quarter 2007 Financial Results
10. CCPM Issues Statement on FDAs GIVE Initiative
11. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Dec. 7, 2016  Muse bio, a privately-held company ... announced that Dr. Kevin Ness has been ... of Directors. Kevin succeeds Muse bio,s ... company,s Chief Science Officer as well as remains Slade ... the BioDesign Center at the RAS Energy Institute at ...
(Date:12/7/2016)... YORK and ANN ARBOR, Mich. ... privately held biopharmaceutical company developing breakthrough immune modulatory medicines, ... trial of the Company,s lead therapeutic candidate, LYC-30937- E ... is often a debilitating skin disease that is estimated ... the United States , with approximately 1.5 ...
(Date:12/7/2016)... SAN DIEGO , December 7, 2016 ... published in the International Journal of Molecular Sciences a team ... 1 ] have demonstrated that expression of ... prognoses.  These scientists tested for NR2F6 in patient,s cervical cancer ... of their tumors. "This is an interesting study ...
(Date:12/7/2016)... Boston, MA and Azusa, CA (PRWEB) , ... ... ... commercial provider of distributed wastewater treatment and resource recovery solutions for industrial facilities, ... Brewing Company , will be the first to use Cambrian’s novel water-energy purchase ...
Breaking Biology Technology:
(Date:12/6/2016)... Ind. , Dec. 6, 2016  Zimmer Biomet Holdings, ... it has priced an offering of €500.0 million principal amount ... million principal amount of its 2.425% senior unsecured notes due ... expected to occur on December 13, 2016, subject to the satisfaction ... an annual basis. The ...
(Date:12/6/2016)... Valencell , the leading innovator in performance biometric ... consecutive year of triple digit growth for its PerformTek ... 360 percent increase in companies who have acquired Valencell ... sales of its wrist and ear Benchmark™ sensor systems, ... hearables for fitness and healthcare applications. ...
(Date:12/6/2016)... 2016 Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, and the ... five (5) year funding commitment by Securus to ... rehabilitation and reentry support to more inmates and ... 2004, the Prison Entrepreneurship Program (PEP) is an ...
Breaking Biology News(10 mins):